FDA NDC
Myfembree
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 72974-415
- Proprietary name
- Myfembree
- Nonproprietary name
- relugolix, estradiol hemihydrate, and norethindrone acetate
- Labeler
- Sumitomo Pharma America, Inc
- Dosage form
- TABLET, FILM COATED
- Strength
- 40 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted relugolix, estradiol hemihydrate, and norethindrone acetate?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.